Medical News

RSS

Ta`am Teva Altman, Probi sign agreement to launch dietary supplement for gut health

Probi has signed an agreement giving Ta`am Teva Altman rights to launch Probi's dietary supplement for gut health based on Lp299v™ in Israel. The launch is planned to take place in the second quarter of 2011.

3 Feb 2011

New England Biolabs expands line of reagents for sample preparation

New England Biolabs has expanded its line of reagents for sample preparation upstream of next generation sequencing to include NEBNext® Small RNA Sample Prep Set 1 for sequencing on the Illumina® platforms, and NEBNext Small RNA Sample Prep Set 3 for sequencing on LIFE's SOLiD™ platform. These new products offer a new and unique protocol, which results in higher yields and lower adaptor-dimer formation, as compared to other protocols.

From New England Biolabs 3 Feb 2011

Malaria transmission to decline in Burundi because of global warming

Malaria transmission will not increase because of global warming in the African nation of Burundi according to a statistical analysis by researchers in Austria and Burundi. Writing in the International Journal of Global Warming, the team explains that rising temperatures will lead to lower humidity and rainfall which will shorten the lifespan of mosquitoes carrying malaria.

3 Feb 2011

Politico looks at how proposed budget cuts could affect U.S. foreign aid, including global health funding

Politico examines how Republicans' proposed budget cuts could affect foreign aid funding. The House Republican majority has recommended combining President Barack Obama's "State and foreign aid requests with 'nonsecurity' domestic spending and to cut appropriations to 2008 levels."

3 Feb 2011

Virginia Autism Project applauds House for historic bill requiring insurers to cover autism for children

Parents of autistic children throughout Virginia cleared a major hurdle today when the House of Delegates voted 74-24 to require insurers to provide autism coverage for children ages 2-6. The Virginia Autism Project applauds the House for its historic vote, which may signal then end of a more than decade-long fight for autism coverage in the commonwealth.

3 Feb 2011

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the clinical study, SINGLE (ING114467), designed to support a new fixed-dose combination (FDC) therapy for the treatment of HIV.

3 Feb 2011

Economist Conferences to holding 17th annual The Pharma Summit 2011 in London

Economist Conferences is holding its 17th annual The Pharma Summit 2011 in London on Thursday February 10 2011. The theme this year is 'Reinventing Pharma for a new generation' and will bring together over 150 senior executives from across the Pharma sector, including some of the industry's most influential names.

3 Feb 2011

Senate repeals small piece of health law, but Republican attempt at overall repeal fails

Senate Republicans failed to muster enough votes to repeal the health law. But a vote to delete a small, revenue-raising provision of the sweeping law did pass, in a bipartisan vote.

3 Feb 2011

Fidaxomicin demonstrates 45% reduction in recurrences vs. existing treatment for C. difficile infection

Clostridium difficile infection (CDI) is a significant and growing problem in hospitals and other health care facilities, but no new drugs to treat the condition have been developed in several decades. However, a large-scale, phase 3 trial conducted by Canadian and U.S. researchers shows that the new antibiotic Fidaxomicin is superior to existing treatments, demonstrating a 45 percent reduction in recurrences vs. the existing licensed treatment.

3 Feb 2011

Lead exposure can lead to high blood pressure in pregnant women: Study

Even minute amounts of lead may take a toll on pregnant women, according to a study published by Lynn Goldman, M.D., M.S., M.P.H., Dean of George Washington University's School of Public Health and Health Services in D.C., and colleagues, in the journal Environmental Health Perspectives.

3 Feb 2011

Losartan improves effectiveness of nanotherapeutics against cancer

Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibers that characterizes most solid tumors, improved the effectiveness of two nanotherapeutics against several types of cancer.

3 Feb 2011

Study reveals how MMSET gene enables disease-causing mutations to occur

For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities. What hasn't been clear, however, is how the body's genome sustains such destructive glitches in the first place.

3 Feb 2011

Metamark announces Nature journal published landmark prostate cancer study results

Metamark Genetics, Inc., a privately-held oncology molecular diagnostics company, today announced results from a landmark prostate cancer study published as an Advance Online Publication in the journal Nature.

3 Feb 2011

HMORN, iSAEC collaborate to enroll subjects in SAE research project using EMR database

The International Serious Adverse Events Consortium announced today a new collaboration with the HMO Research Network to enroll subjects in research to identify genetic markers that may help predict risk associated with a range of serious drug-related adverse events.

3 Feb 2011

New findings: For-profit hospices may choose cheaper-to-treat patients

Study results released Tuesday by the Journal of the American Medical Association report that for-profit hospice services may be selecting patients who are less expensive to treat — leaving the pricier patients to nonprofit agencies (Brown, 2/1).

3 Feb 2011

Viewpoints: N.Y. Times slams Vinson ruling as WSJ, Wash post parse it; Violence in hospitals; Bending health cost curve

A ruling by a Federal District Court judge in Florida that the entire health care reform law is unconstitutional was a breathtaking example of judicial activism and overreach. It is hard not to believe this decision was driven at least in part by ideology.

3 Feb 2011

Concert and WRAIR enter CRADA to evaluate novel compound for seizure protection associated with TBI

Concert Pharmaceuticals, Inc. today announced that it has entered into a Cooperative Research and Development Agreement with the Walter Reed Army Institute of Research. The CRADA will allow the WRAIR to conduct preclinical testing on a novel compound derived from Concert's DCE Platform™ (deuterated chemical entity platform) for seizure protection associated with traumatic brain injury, a major public health concern.

3 Feb 2011

Food scientists pinpoint complex chemistry behind coffee's antioxidant benefits

Food scientists at the University of British Columbia have been able to pinpoint more of the complex chemistry behind coffee's much touted antioxidant benefits, tracing valuable compounds to the roasting process.

3 Feb 2011

Inspiration presents IB1001 PK data at European haemophilia congress

Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. (Inspiration) presented pharmacokinetic (PK) data on its lead product, IB1001, a recombinant factor IX (FIX) for the treatment and prevention of bleeding in individuals with hemophilia B.

3 Feb 2011

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announced today that data from the pivotal Phase III study with GARDASIL in males were published in the February 3 issue of the New England Journal of Medicine.

3 Feb 2011

Medical News

Ta`am Teva Altman, Probi sign agreement to launch dietary supplement for gut health

New England Biolabs expands line of reagents for sample preparation

Malaria transmission to decline in Burundi because of global warming

Politico looks at how proposed budget cuts could affect U.S. foreign aid, including global health funding

Virginia Autism Project applauds House for historic bill requiring insurers to cover autism for children

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Economist Conferences to holding 17th annual The Pharma Summit 2011 in London

Senate repeals small piece of health law, but Republican attempt at overall repeal fails

Fidaxomicin demonstrates 45% reduction in recurrences vs. existing treatment for C. difficile infection

Lead exposure can lead to high blood pressure in pregnant women: Study

Losartan improves effectiveness of nanotherapeutics against cancer

Study reveals how MMSET gene enables disease-causing mutations to occur

Metamark announces Nature journal published landmark prostate cancer study results

HMORN, iSAEC collaborate to enroll subjects in SAE research project using EMR database

New findings: For-profit hospices may choose cheaper-to-treat patients

Viewpoints: N.Y. Times slams Vinson ruling as WSJ, Wash post parse it; Violence in hospitals; Bending health cost curve

Concert and WRAIR enter CRADA to evaluate novel compound for seizure protection associated with TBI

Food scientists pinpoint complex chemistry behind coffee's antioxidant benefits

Inspiration presents IB1001 PK data at European haemophilia congress

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News